[Translation] Phase Ib Multicenter, Open Label, Dose Escalation and Expansion Study of CT-3505 Capsules in Patients with LTK Gene Fusion Positive Advanced Solid Tumors
主要目的:评价 CT-3505 胶囊在 LTK 基因融合阳性的晚期实体瘤患者中的安全性、耐受性及 II 期临床试验推荐剂量(RP2D)。
次要目的:评价 CT-3505 胶囊在 LTK 基因融合阳性的晚期实体瘤患者中的初步疗效。
[Translation] Main objective: To evaluate the safety, tolerability and recommended dose of phase II clinical trial (RP2D) of CT-3505 capsules in patients with LTK gene fusion-positive advanced solid tumors.
Secondary objective: To evaluate the preliminary efficacy of CT-3505 capsules in patients with LTK gene fusion-positive advanced solid tumors.